Recruiting NA Postpartum Depression

New treatment option for Postpartum Depression

Official title Mother-infant Bonding in the Brain: a Mindfulness-based Intervention

ClinicalTrials.gov ID: NCT05830266

What this study is testing

What it's testing
The study investigates the effectiveness of the mindfulness-based intervention "Mindful with your Baby" in women with babies between 5-9 months postpartum who experience heightened levels of postpartum depression, anxiety and/or parental stress. The intervention "Mindful with your Baby" is one of the very few interventions for maternal postnatal mental health issues that takes the bond between mother and infant into account.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older, women only

You may be able to join if

  • Pregnant women (18+y).
  • First antenatal visit \< 12 weeks.
  • Score above cut off on the Edinburgh Postnatal Depression Scale (EPDS), the anxiety subscale of the Symptom Checklist (SCL-90) and/or the Parental...
  • Dutch-speaking or understanding Dutch.

You likely can't join if

  • Gemelli pregnancy (or higher order pregnancy).
  • Known endocrine disorder before pregnancy (diabetes-I, Rheumatoid arthritis).
  • Severe psychiatric disease (schizophrenia, borderline or bipolar disorder).
  • HIV.
  • Drug or alcohol addiction problems.
  • Any other disease resulting in treatment with drugs that are potentially adverse for the fetus and need careful follow-up during pregnancy.
See the full eligibility criteria
Who can join
  • Pregnant women (18+y).
  • First antenatal visit \< 12 weeks.
  • Score above cut off on the Edinburgh Postnatal Depression Scale (EPDS), the anxiety subscale of the Symptom Checklist (SCL-90) and/or the Parental Stress Questionnaire (PSQ) at 8-10 weeks postpartum.
  • Dutch-speaking or understanding Dutch.
What rules you out
  • Gemelli pregnancy (or higher order pregnancy).
  • Known endocrine disorder before pregnancy (diabetes-I, Rheumatoid arthritis).
  • Severe psychiatric disease (schizophrenia, borderline or bipolar disorder).
  • HIV.
  • Drug or alcohol addiction problems.
  • Any other disease resulting in treatment with drugs that are potentially adverse for the fetus and need careful follow-up during pregnancy.
  • No access to the internet.

The study team makes the final eligibility decision.

Where it's taking place

  • Tilburg, North Brabant, Netherlands

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Tilburg, North Brabant, Netherlands. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.